C Grohé

689 total citations
34 papers, 529 citations indexed

About

C Grohé is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C Grohé has authored 34 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in C Grohé's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). C Grohé is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). C Grohé collaborates with scholars based in Germany, United States and Spain. C Grohé's co-authors include H. Vetter, Stefan Kahlert, Jeanette Schulz‐Menger, M. Allewelt, Fabian Muehlberg, H. Semper, Ingo Schmidt‐Wolf, A. Hirner, JK Rockstroh and D. Huhn and has published in prestigious journals such as Circulation Research, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

C Grohé

32 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Grohé Germany 10 150 138 110 101 92 34 529
Benedetta Chiodini Belgium 11 100 0.7× 35 0.3× 75 0.7× 81 0.8× 60 0.7× 20 449
Sonali Pechlivanis Germany 13 129 0.9× 33 0.2× 234 2.1× 97 1.0× 113 1.2× 28 643
Jensen United States 8 155 1.0× 60 0.4× 139 1.3× 41 0.4× 27 0.3× 11 474
Alessandra Gatti Italy 14 54 0.4× 44 0.3× 90 0.8× 31 0.3× 132 1.4× 28 452
Saburo Murakami Japan 15 172 1.1× 112 0.8× 95 0.9× 20 0.2× 147 1.6× 37 613
Myoung Ju Koh South Korea 9 58 0.4× 51 0.4× 78 0.7× 54 0.5× 54 0.6× 14 412
Maja Cigrovski Berković Croatia 17 165 1.1× 39 0.3× 148 1.3× 57 0.6× 510 5.5× 82 914
Marloes G. J. van Dongen Netherlands 9 86 0.6× 130 0.9× 88 0.8× 90 0.9× 57 0.6× 10 434
Yuan Shi China 11 113 0.8× 87 0.6× 139 1.3× 13 0.1× 58 0.6× 39 398
Yuping Zhang China 13 82 0.5× 126 0.9× 217 2.0× 67 0.7× 38 0.4× 25 546

Countries citing papers authored by C Grohé

Since Specialization
Citations

This map shows the geographic impact of C Grohé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Grohé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Grohé more than expected).

Fields of papers citing papers by C Grohé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Grohé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Grohé. The network helps show where C Grohé may publish in the future.

Co-authorship network of co-authors of C Grohé

This figure shows the co-authorship network connecting the top 25 collaborators of C Grohé. A scholar is included among the top collaborators of C Grohé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Grohé. C Grohé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuboi, Masahiro, Yi‐Long Wu, Jian He, et al.. (2020). 356MO Osimertinib adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence. Annals of Oncology. 31. S1378–S1378. 3 indexed citations
2.
Tsuboi, Masahiro, Yi‐Long Wu, Jie He, et al.. (2020). LBA1 Osimertinib adjuvant therapy in patients (pts) with resected EGFR mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence. Annals of Oncology. 31. S1177–S1177. 6 indexed citations
3.
4.
Tronnier, Michael, et al.. (2018). Tuberculosis cutis luposa (Lupus vulgaris). Pneumologie. 72(S 01). S94–S94.
5.
Wirtz, Heidi S., Antje Prasse, Jens Klotsche, et al.. (2016). Predictors Of Mortality In Patients With Idiopathic Pulmonary Fibrosis Under Clinical Practice Conditions: Insights-Ipf Registry. American Journal of Respiratory and Critical Care Medicine. 3 indexed citations
6.
Laffert, Maximilian von, Peter Schirmacher, Arne Warth, et al.. (2016). ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?. Lung Cancer. 103. 1–5. 15 indexed citations
7.
Semper, H., Fabian Muehlberg, Jeanette Schulz‐Menger, M. Allewelt, & C Grohé. (2016). Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung. Lung Cancer. 99. 117–119. 82 indexed citations
8.
Laffert, Maximilian von, Peter Schirmacher, Arne Warth, et al.. (2016). Stellungnahme der DGP und der AG Thorakale Onkologie der AG Onkologie/Deutsche Krebsgesellschaft e. V. zur ALK-Testung beim NSCLC. Der Pathologe. 37(2). 187–192. 6 indexed citations
9.
10.
11.
Makin, Andrew, et al.. (2013). 40PD SMALL CELL LUNG CANCER AND HYPONATREMIA: INTERIM RESULTS FROM A PROSPECTIVE, OBSERVATIONAL, GLOBAL REGISTRY. Lung Cancer. 80. S18–S18. 2 indexed citations
12.
13.
14.
Skowasch, Dirk, et al.. (2011). Diabetes insipidus bei Neurosarkoidose. Pneumologie. 65(8). 496–497. 2 indexed citations
15.
Wilkens, Heinrike, Iréne Lang, Jürgen Behr, et al.. (2010). Chronisch thromboembolische pulmonale Hypertonie. DMW - Deutsche Medizinische Wochenschrift. 135(S 03). S125–S130. 12 indexed citations
16.
Knuefermann, Pascal, Markus Velten, Heidi Ehrentraut, et al.. (2008). Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9. Cardiovascular Research. 78(1). 26–35. 72 indexed citations
17.
Pabst, Stefan, Georg Baumgarten, Martina Lennarz, et al.. (2006). Toll-like receptor (TLR) 4 Asp299Gly and Thr399Ile polymorphisms are associated with a chronic progressive course of pulmonary sarcoidosis. Pneumologie. 59(12). 2 indexed citations
18.
Schmidt‐Wolf, Ingo, JK Rockstroh, H. Schüller, et al.. (2003). Malignant thymoma: current status of classification and multimodality treatment. Annals of Hematology. 82(2). 69–76. 49 indexed citations
19.
Grohé, C, et al.. (1998). Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. Journal of Endocrinology. 156(2). R1–R7. 152 indexed citations
20.
Bassel‐Duby, Rhonda, C Grohé, W J Parsons, et al.. (1993). Sequence elements required for transcriptional activity of the human myoglobin promoter in intact myocardium.. Circulation Research. 73(2). 360–366. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benedetta Chiodini Breakdown of academic impact, for papers by Sonali Pechlivanis Breakdown of academic impact, for papers by Jensen Breakdown of academic impact, for papers by Alessandra Gatti Breakdown of academic impact, for papers by Saburo Murakami Breakdown of academic impact, for papers by Myoung Ju Koh Breakdown of academic impact, for papers by Maja Cigrovski Berković Breakdown of academic impact, for papers by Marloes G. J. van Dongen Breakdown of academic impact, for papers by Yuan Shi Breakdown of academic impact, for papers by Yuping Zhang
Rankless by CCL
2026